BSE Code: | NSE Code: | ISIN: | Sector:
Research Report Detail
|Report Date||Call||Price@Call||Target Price
|Current Status||Time Horizon|
|Open|| Long (1Y)
Edelweiss Maintains ‘Buy’ On Thyrocare Technologies
According to Edelweiss, Thyrocare Technologies' Q2 earnings witnessed a slowdown due to increased competition in preventive healthcare, as Dr Lal and several other players forayed into the wellness space with aggressively priced packages. Given the rising competitive intensity, the brokerage remains cautious on the diagnostics sector.